• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Neurotech International

Neurotech International

ASX:NTI

  • Home
  • Corporate
    • Board and Management
    • Corporate Directory
    • Corporate Governance
  • Development Programs
    • Biopharmaceutical Trials
    • Combination Therapy
    • Pathways to Commercialisation
    • Mente Technology
  • Investors
    • Investor Dashboard
    • ASX Announcements
    • Company Reports
    • Presentations
    • Research
    • News & Media
  • Contact

Board &
Management

Dr Alexandra Andrews

Chief Operating Officer

PhD Neuroscience, BBMed Sci (Hons1st)

Expertise in corporate development, investor engagement, product development and commercialisation, clinical trials and regulatory environments. Former Director of Operations at NeuroScientific Biopharmaceuticals.

Mark Davies

Chairman

BCom

More than 20 years’ experience in trading, investment banking & providing corporate advice. Specialises in providing corporate advice & capital raising services to emerging companies seeking business development opportunities and funding from the Australian market. Managing Director of 1861 Capital and co-founder of investment banking firm, Cygnet Capital.

Dr Thomas Duthy

Executive Director

PhD Molecular Microbiology, MBA

Dr Duthy has over 18 years of direct financial market and executive-level/Board experience with ASX listed companies. Nemean Group provides corporate advisory and investor relations services in the Life Sciences and Technology sectors.

Gerald Quigley

Director of Public Relations

B(Pharm)

Pharmacist and consumer health commentator. Leading media health commentator heard each week on television and radio stations across Australia. Extensive knowledge relating to pharmaceutical/ nutraceutical product development, dispensing & marketing in addition to product positioning within the relevant regulatory landscapes (eg. TGA, FDA).

Winton Willesee

Non-Executive Director

MCom, FFin, CPA, GAICD, FGIA/FCG

Experienced company director with over 20 years experience in various roles within the Australian capital markets. Core expertise in strategy, company development, corporate governance, company public listings, merger and acquisition transactions and corporate finance.

Footer

Suite 5 CPC, 145 Stirling Highway
Nedlands WA 6009
Australia

moc.l1679466658anoit1679466658anret1679466658nihce1679466658torue1679466658n@ofn1679466658i1679466658

+61 (8) 9389 3130

Subscribe to our latest announcements

Name*
This field is for validation purposes and should be left unchanged.

Copyright © 2023 Neurotech International • Site by White Noise Communications

Download prospectus